Overview

Effects of ACS in Twin With LPB: Study Protocol for a RCT

Status:
Recruiting
Trial end date:
2022-12-31
Target enrollment:
Participant gender:
Summary
This study will be the first study that evaluates the effectiveness of antenatal corticosteroid (ACS) in late preterm twin neonates.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Seoul National University Hospital
Treatments:
Betamethasone
Betamethasone benzoate
Betamethasone sodium phosphate
Betamethasone Valerate
Betamethasone-17,21-dipropionate